GOVX GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company with a robust pipeline of human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.

$3.56  -0.13 (-3.52%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/31/1997
Outstanding shares:  6,381,541
Average volume:  2,754,677
Market cap:   $23,547,886
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    373678507
ISIN:        US3736785078
Valuation   (See tab for details)
PE ratio:   -3.69
PB ratio:   1.26
PS ratio:   49.87
Return on equity:   -34.24%
Net income %:   -1,305.45%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy